Biopharmaceutical industry responds to invasion of Ukraine

Following the invasion of Ukraine, the research-based biopharmaceutical industry is responding through solidarity, supply and support. We condemn the invasion of Ukraine and stands in solidarity with its people. We are working hard to ensure the resilience of the medicines supply chain so that people in Ukraine, in neighbouring EU Member States, in Russia and in other countries get the medicines they need. We are providing ​humanitarian ​support through medical supplies​ and financial​ aid to NGOs.

This page, managed by our colleagues at EFPIA, will be updated regularly. It shows how the industry is responding to the crisis.

ENDS